CITE−seq conjugates antibody bar−codes to capture cell−surface proteins alongside mRNA, providing a direct measure of PD−L1, TIM−3, TIGIT, and CTLA−4 abundance on tumour and immune subsets (28, 29). This evidence concerns the gene HAVCR2 and neoplasm.